Twist Bioscience stock slides 2.94% as company touts innovation roots, Twist Bioscience

Traders Union
All News
Business & Wealth
Companies
Twist Bioscience slides 2.94% today

Highlights

TWST maintains a strong bullish trend, trading well above key moving averages and yearly lows despite recent pullback.
Momentum signals show an overbought market with elevated volatility and mixed short-term indicators, suggesting the rally may be stretched.
The stock is forecast to trade between $95.00 and $105.00 next week, with over 80% probability of additional upside barring a break below $95.00.

The company described its mission as 'writing the code of life.' Twist Bioscience extended Independence Day wishes from its team.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Bullish trend sustained as price holds above key technical supports

TWST is trading at $99.24, which is above the MA-20 ($84.91), MA-50 ($69.62), and MA-200 ($46.34), confirming that short-, medium-, and long-term trends remain strongly bullish. The Ichimoku Kijun level on D1 sits at $84.21, providing immediate support just below the current price. Near-term support appears at the Ichimoku Kijun ($84.21), followed by key support at MA-50 ($69.62). Immediate resistance is found at the MA-5 EMA cluster ($99.16) and the MA-5 SMA ($100.51).

Mixed momentum and overbought signals as rally faces pullback risk

Momentum signals are mixed: MACD on D1 indicates upward momentum, and ADX is strong at 41.51, but Stoch RSI is neutral and CCI is overbought, suggesting the rally is stretched. BBP signals an overbought market with buyers dominating, while RSI is elevated at 71.90. AO remains neutral, showing some indecision despite the broad trend. TWST has fallen $0.60 (0.60%) over the past week, now trading slightly below the weekly close of $99.84. The price sits in the lower part of the weekly range, and weekly volatility stands at 10.55%. In today's session, the stock is down 2.94%, reflecting a steady pullback from recent highs after touching $105.41.

Upside bias favored as technicals support consolidation above breakout zone

Looking ahead, the expected price corridor for the next week is $95.00–$105.00, normalized to align with current market dynamics and observed volatility. With all four key weekly technical indicators in Buy territory (RSI-W1, ADX-W1, MACD-W1, and MA-50-W1), the probability of further price increases is very high (more than 80%), while a decline is less likely. The baseline scenario anticipates sideways movement between $95.00 and $105.00. A bullish scenario would see prices break above $105.00, targeting new post-52-week highs, while a bearish break below $95.00 could trigger a move toward the $90.00–$92.00 area. This range remains near the 52-week high of $105.41 and is well above the yearly low at $23.30, highlighting the strong longer-term uptrend.

Previously it was reported that Twist Bioscience maintained a robust bullish trend, supported by strong technical momentum and upside expectations. In the current context, investors should closely monitor for any decisive shifts in price action that could define the next prevailing scenario and set the stage for either continued strength or a corrective pullback.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.